Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yuta Ushida"'
Autor:
Yuta Ushida, Eiji Shinozaki, Keisho Chin, Mitsukuni Suenaga, Daisuke Takahari, Masato Ozaka, Mariko Ogura, Takashi Ichimura, Takeru Wakatsuki, Kensei Yamaguchi
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 601-608 (2018)
Background: Colorectal cancer (CRC) with lung metastases has an unfavorable prognosis. However, nowadays, even advanced CRC can have a favorable outcome in certain cases. A complete response (CR) is a rare event in advanced CRC with lung metastases.
Externí odkaz:
https://doaj.org/article/de2e4de53b094e818ba71695fdf17ada
Autor:
Yuta, Ushida, Yosuke, Inoue, Atsushi, Oba, Takafumi, Mie, Hiromichi, Ito, Yoshihiro, Ono, Takafumi, Sato, Masato, Ozaka, Takashi, Sasaki, Akio, Saiura, Naoki, Sasahira, Yu, Takahashi
Publikováno v:
Annals of Surgical Oncology. 29:5038-5050
The prognosis of initially unresectable pancreatic cancer (UR-PC) has improved since the introduction of FOLFIRINOX (FFX) or gemcitabine plus nab-paclitaxel (GNP) treatment. Nonetheless, the indications and optimal timing for conversion to resection
Autor:
Yuta, Ushida, Takafumi, Sato, Tomotaka, Kato, Yasuyuki, Shigematsu, Hiromichi, Ito, Takeshi, Suzuki, Yosuke, Inoue, Yoshihiro, Ono, Atsushi, Oba, Yu, Takahashi
Publikováno v:
Clinical Journal of Gastroenterology. 15:427-432
A 67-year-old man presented with hemorrhagic shock due to the rupture of hepatic tumor and underwent emergency partial resection of the right liver. Pathological examination revealed hepatic angiosarcoma with involvement in its surgical margin. Six m
Autor:
Yoshihiro Ono, Atsushi Oba, Hiromichi Ito, Genki Watanabe, Yuta Ushida, Akio Saiura, Yu Takahashi, Takafumi Sato, Yosuke Inoue
Publikováno v:
Annals of Surgical Oncology. 29:378-388
Neoadjuvant therapy is used for borderline resectable pancreatic ductal adenocarcinoma (PDAC) with high risk of incomplete resection and early recurrence. Because distal PDAC is rare, the optimal criteria for neoadjuvant therapy specific for distal P
High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment
Autor:
Yosuke Inoue, Yoshihiro Ono, Atsushi Oba, Yuta Ushida, Akio Saiura, Hiromichi Ito, Yoshihiro Mise, Takafumi Sato, Yu Takahashi
Publikováno v:
Pancreatology. 21:130-137
Background Previous studies on borderline resectable (BR) pancreatic cancer (PC) included patients with heterogenous preoperative states; however, the definition of resectability for PC has evolved. We aimed to investigate the prognostic factors for
Autor:
Yuta Ushida, Yosuke Inoue, Atsushi Oba, Takafumi Mie, Hiromichi Ito, Yoshihiro Ono, Takafumi Sato, Masato Ozaka, Takashi Sasaki, Akio Saiura, Naoki Sasahira, Yu Takahashi
Publikováno v:
Annals of Surgical Oncology. 29:5053-5054
Autor:
Yuta Ushida, Hiromichi Ito, Yoshihiro Ono, Yosuke Inoue, Yu Takahashi, Takafumi Sato, Atsushi Oba
Publikováno v:
Journal of Surgical Case Reports
A 53-year-old man with prior history of resection of liposarcoma in his leg presented with gallbladder mass. Computed tomography showed 4-cm tumor at gallbladder fundus with weak enhancement with IV contrast. Differential diagnoses included hemangiom
Autor:
TAKAFUMI MIE, MASATO OZAKA, TAKESHI OKAMOTO, TSUYOSHI TAKEDA, YUTA USHIDA, CHINATSU MORI, TAKAAKI FURUKAWA, YUTO YAMADA, AKIYOSHI KASUGA, MASATO MATSUYAMA, TAKASHI, SASAKI, YOUSUKE INOUE, YU TAKAHASHI, NAOKI SASAHIRA
Publikováno v:
In Vivo; Nov/Dec2022, Vol. 36 Issue 6, p2844-2851, 8p
Autor:
Genki, Watanabe, Yuta, Ushida, Atsushi, Oba, Yoshihiro, Ono, Takafumi, Sato, Yosuke, Inoue, Yu, Takahashi, Akio, Saiura, Hiromichi, Ito
Publikováno v:
Annals of surgical oncology. 29(1)
Neoadjuvant therapy is used for borderline resectable pancreatic ductal adenocarcinoma (PDAC) with high risk of incomplete resection and early recurrence. Because distal PDAC is rare, the optimal criteria for neoadjuvant therapy specific for distal P
Autor:
Yuta Ushida, Genki Watanabe, Yoshihiro Ono, Yosuke Inoue, Akio Saiura, Takafumi Sato, Atsushi Oba, Yu Takahashi, Hiromichi Ito
Publikováno v:
Annals of Surgical Oncology. 28:742-743